Fredun Pharmaceuticals Live BSE/NSE | Fredun Pharmaceuticals Fundamenta data | Fredun Pharmaceuticals Balance sheet | Fredun Pharmaceuticals Quarterly Results | Fredun Pharmaceuticals Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

110.13
64.41
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

141.98
0.24%
2.66

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

30.35
21.68
23.76

EBITDA CAGR (%)

10 Years
5 Years
3 Years

27.05
16.39
7.85

PAT CAGR (%)

10 Years
5 Years
3 Years

57.68
12.17
2.78

P:E (Median)

8 Years
5 Years
3 Years

-
-
37.99

P:BV (Average)

8 Years
5 Years
3 Years

-
-
1.87

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
15.42

Quarterly Results

Standalone Figures in Rs. Crores

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 14 28 -51% 25 32 -22% 28 27 5% 32 22 44%
Expenses 12 26 -53% 23 27 -14% 25 23 9% 30 19 54%
EBITDA 1 2 -36% 2 5 -60% 2 3 -24% 2 3 -19%
EBIDTM 9% 7% 8% 15% 9% 12% 7% 13%
Other Income 0 0 -100% 0 0 0 0 0 0 0 0 0
Interest 1 1 -40% 1 2 -37% 1 1 66% 1 0 156%
Depreciation 0 0 0% 0 0 34% 0 0 45% 0 0 176%
PBT 0 0 -83% 0 3 -87% 1 2 -40% 1 2 -61%
Tax 0 0 0 1 2 -65% 0 0 0 0 0 0
PAT 0 0 -83% 0 1 - 1 2 -40% 1 2 -61%
PATM 0% 1% -1% 3% 4% 6% 3% 10%
EPS 0.09 0.58 -84% -0.56 2.79 - 2.55 4.27 -40% 2.19 5.66 -61%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 99 113 97 60 57 42 25 21 15 12 8 Net Sales Growth -10% 16% 63% 5% 34% 67% 19% 41% 29% 47% Cost Of Goods Sold 69 81 60 40 25 19 15 10 7 5 4 Gross Profit 30 32 37 20 32 23 10 12 8 6 4 GP Margin 31% 28% 38% 34% 57% 55% 40% 54% 55% 54% 56% Total Expenditure 91 105 87 54 53 38 24 20 14 11 7 Power & Fuel Cost - 3 3 2 2 1 1 1 1 0 0 % Of Sales - 3% 3% 3% 3% 3% 3% 3% 4% 4% 4% Employee Cost - 9 8 5 5 4 3 3 2 2 1 % Of Sales - 8% 8% 9% 9% 9% 13% 13% 13% 14% 16% Manufacturing Exp. - 5 4 1 15 9 1 3 2 3 1 % Of Sales - 4% 4% 2% 27% 22% 3% 16% 16% 22% 14% General & Admin Exp. - 5 7 4 3 2 2 2 0 0 0 % Of Sales - 5% 7% 6% 6% 5% 7% 7% 3% 3% 6% Selling & Distn. Exp. - 2 3 3 3 3 2 0 0 0 0 % Of Sales - 2% 3% 4% 6% 6% 6% 2% 0% 0% 3% Miscellaneous Exp. - 0 2 0 0 0 0 1 2 1 0 % Of Sales - 0% 2% 0% 0% 1% 1% 6% 10% 8% 3% EBITDA 8 8 10 6 3 4 2 1 1 0 1 EBITDA Margin 8% 7% 11% 10% 6% 9% 7% 7% 9% 3% 10% Other Income 0 1 0 0 2 1 0 0 0 1 0 Interest 4 4 3 2 2 2 1 1 1 1 1 Depreciation 2 2 1 1 1 1 1 1 0 0 0 PBT 2 2 6 3 2 2 1 0 0 0 0 Tax 1 1 2 1 1 1 0 0 0 0 0 Tax Rate 26% 24% 28% 34% 36% 42% 50% 47% 80% 0% 67% PAT 2 2 4 2 1 1 0 0 0 0 0 PAT before Minority Interest 2 2 4 2 1 1 0 0 0 0 0 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 2% 2% 5% 3% 3% 3% 1% 1% 0% -2% 0% PAT Growth -68% -57% 155% 22% 34% 312% 8% 2,300% 104% -1,300% EPS 4.30 4.75 11.15 4.38 3.58 2.68 0.65 0.60 0.03 -0.60 0.05

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

113

Net Sales Growth

-10%

16%

63%

34%

67%

19%

41%

29%

47%

Cost Of Goods Sold

Gross Profit

GP Margin

31%

28%

38%

34%

57%

55%

40%

54%

55%

54%

56%

Total Expenditure

105

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

13%

14%

16%

Manufacturing Exp.

% Of Sales

27%

22%

16%

22%

14%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

10%

EBITDA

EBITDA Margin

11%

10%

Other Income

Interest

Depreciation

PBT

Tax

Tax Rate

26%

24%

28%

34%

36%

42%

50%

47%

80%

67%

PAT

PAT before Minority Interest

Minority Interest

PAT Margin

-2%

PAT Growth

-68%

-57%

155%

22%

34%

312%

2,300%

104%

-1,300%

EPS

4.30

4.75

11.15

4.38

3.58

2.68

0.65

0.60

0.03

-0.60

0.05

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 41 39 22 7 4 3 3 3 3 3 Share Capital 4 4 3 5 3 3 3 3 3 3 Total Reserves 37 35 19 2 1 0 0 0 0 0 Non-Current Liabilities 14 13 4 8 7 4 3 2 2 2 Secured Loans 12 11 0 0 0 0 2 1 1 2 Unsecured Loans 0 0 0 7 6 3 0 0 0 0 Long Term Provisions 2 1 3 0 0 0 0 0 0 0 Current Liabilities 78 53 53 40 32 16 12 10 8 5 Trade Payables 44 34 39 23 16 7 5 3 4 1 Other Current Liabilities 8 9 1 8 7 3 2 3 1 1 Short Term Borrowings 23 9 10 8 7 5 4 3 3 2 Short Term Provisions 3 2 3 2 2 1 1 0 0 0 Total Liabilities 133 105 79 56 43 23 18 15 13 10 Net Block 31 31 16 20 15 8 7 6 6 5 Gross Block 37 35 25 28 21 13 12 11 10 9 Accumulated Depreciation 6 4 9 7 6 5 5 5 4 4 Non Current Assets 32 32 28 21 15 10 8 7 7 6 Capital Work in Progress 0 0 11 0 0 1 0 0 0 0 Non Current Investment 0 0 0 0 0 0 0 0 0 0 Long Term Loans & Adv. 1 1 0 0 0 0 1 0 0 0 Other Non Current Assets 0 0 0 0 0 0 0 1 1 1 Current Assets 101 73 51 35 28 13 10 8 6 4 Current Investments 0 0 0 0 0 0 0 0 0 0 Inventories 50 41 18 7 10 4 4 3 3 1 Sundry Debtors 33 18 15 20 11 5 3 2 2 1 Cash & Bank 3 1 1 1 1 1 0 1 0 0 Other Current Assets 15 12 9 1 5 3 3 2 1 1 Short Term Loans & Adv. 1 1 8 6 5 1 1 2 1 1 Net Current Assets 23 19 -2 -5 -4 -3 -2 -3 -2 -1 Total Assets 133 105 79 56 43 23 18 15 13 10

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

Share Capital

Total Reserves

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

133

105

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

101

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

-2

-5

-4

-3

-2

-3

-2

-1

Total Assets

133

105

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity -11 1 17 4 3 2 -1 1 0 0 PBT 2 6 2 2 2 1 0 0 0 0 Adjustment 6 2 3 3 2 1 0 1 0 0 Changes in Working Capital -19 -7 13 0 0 0 -2 1 0 0 Cash after chg. in Working capital -11 1 17 5 4 2 -1 2 0 0 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid 0 0 0 -1 -1 0 0 0 0 0 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -1 -5 -8 -7 -6 -3 -2 -1 0 0 Net Fixed Assets -2 1 -8 -7 -6 -3 -2 -1 -1 -1 Net Investments 0 0 0 0 0 0 0 0 0 0 Others 0 -6 0 0 0 0 0 0 1 1 Cash from Financing Activity 14 4 -8 3 3 1 2 0 0 0 Net Cash Inflow / Outflow 2 0 1 -1 1 0 0 0 0 0 Opening Cash & Equivalents 1 1 1 1 1 0 1 0 0 0 Closing Cash & Equivalent 3 1 1 1 1 1 0 1 0 0

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

-11

-1

PBT

Adjustment

Changes in Working Capital

-19

-7

-2

Cash after chg. in Working capital

-11

-1

Interest Paid

Tax Paid

-1

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-1

-5

-8

-7

-6

-3

-2

-1

Net Fixed Assets

-2

-8

-7

-6

-3

-2

-1

Net Investments

Others

-6

Cash from Financing Activity

-8

Net Cash Inflow / Outflow

-1

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 104 98 65 20 16 12 11 10 10 11 ROA 2% 5% 3% 3% 3% 1% 2% 0% -2% 0% ROE 5% 15% 13% 34% 33% 10% 10% 0% -10% 1% ROCE 10% 21% 16% 18% 25% 14% 14% 12% 8% 10% Fixed Asset Turnover 3.15 3.23 2.25 2.33 2.47 1.99 1.91 1.48 1.24 0.93 Receivable days 82 62 109 102 72 62 45 44 45 55 Inventory Days 148 111 78 55 63 57 57 73 62 54 Payable days 138 158 218 146 106 101 87 103 84 78 Cash Conversion Cycle 92 15 -31 12 28 18 16 14 24 31 Total Debt/Equity 0.84 0.49 0.45 2.53 3.92 3.06 2.49 1.84 1.83 1.41 Interest Cover 2 3 2 2 2 2 2 1 1 1

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

104

ROA

-2%

ROE

15%

13%

34%

33%

10%

-10%

ROCE

10%

21%

16%

18%

25%

14%

12%

10%

Fixed Asset Turnover

3.15

3.23

2.25

2.33

2.47

1.99

1.91

1.48

1.24

0.93

Receivable days

109

102

Inventory Days

148

111

Payable days

138

158

218

146

106

101

103

Cash Conversion Cycle

-31

Total Debt/Equity

0.84

0.49

0.45

2.53

3.92

3.06

2.49

1.84

1.83

1.41

Interest Cover

Fredun Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 539730 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Fredun Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 539730 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update